Evidence map›Paper›PMID 25406017›Full record

ArticleEndocrinology2015

Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet.

Tianxu Yang, Lara A Householder, Ellen R Lubbers, Edward O List, Katie Troike, Clare Vesel, Silvana Duran-Ortiz, John J Kopchick, Darlene E Berryman

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Mouse models of growth hormone insensitivity.Reviews in endocrine & metabolic disorders · 2021
    Review
  7. Review
  8. Hormesis in Health and Chronic Diseases.Trends in endocrinology and metabolism: TEM · 2019
    Review
  9. Article
  10. Review
  11. Growth Hormone's Effect on Adipose Tissue: Quality versus Quantity.International journal of molecular sciences · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. The somatotropic axis and aging: Benefits of endocrine defects.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2016
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tianxu YangEdison Biotechnology Institute (T.Y., L.A.H., E.R.L., E.O.L., K.T., C.V., S.D.-O., J.J.K., D.E.B.), School of Applied Health Sciences and Wellness, College of Health Sciences and Professions (T.Y., L.A.H., K.T., S.D.-O., D.E.B.), and Department of Biomedical Sciences (J.K., D.E.B.), Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio 45701.
Lara A Householder
Ellen R Lubbers
Edward O List
Katie Troike
Clare Vesel
Silvana Duran-Ortiz
John J Kopchick
Darlene E Berryman
Ohio University · US

Funding

The Somatotropic Axis and Health Aging: A Search for MechanismsP01AG031736 · NIA · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI BARTKE, ANDRZEJ · 2009 to 2013
$8.4M
NIA NIH HHS AG031736NIA NIH HHS P01 AG031736
6 · The paper itself

Abstract

Reduced GH levels have been associated with improved glucose metabolism and increased longevity despite obesity in multiple mouse lines. However, one mouse line, the GH receptor antagonist (GHA) transgenic mouse, defies this trend because it has reduced GH action and increased adiposity, but glucose metabolism and life span are similar to controls. Slight differences in glucose metabolism and adiposity profiles can become exaggerated on a high-fat (HF) diet. Thus, in this study, male and female GHA and wild-type (WT) mice in a C57BL/6 background were placed on HF and low-fat (LF) diets for 11 weeks, starting at 10 weeks of age, to assess how GHA mice respond to additional metabolic stress of HF feeding. On a HF diet, all mice showed significant weight gain, although GHA gained weight more dramatically than WT mice, with males gaining more than females. Most of this weight gain was due to an increase in fat mass with WT mice increasing primarily in the white adipose tissue perigonadal depots, whereas GHA mice gained in both the sc and perigonadal white adipose tissue regions. Notably, GHA mice were somewhat protected from detrimental glucose metabolism changes on a HF diet because they had only modest increases in serum glucose levels, remained glucose tolerant, and did not develop hyperinsulinemia. Sex differences were observed in many measures with males reacting more dramatically to both a reduction in GH action and HF diet. In conclusion, our findings show that GHA mice, which are already obese, are susceptible to further adipose tissue expansion with HF feeding while remaining resilient to alterations in glucose homeostasis.

Indexed as

AdipocytesAdiposityAnimalsBody WeightCattleDiet, High-FatDisease Models, AnimalEatingFemaleGlucoseGlucose IntoleranceHyperinsulinismInsulinLeptinLiverMaleGlucoseInsulinLeptinReceptors, SomatotropinTriglycerides

Identifiers

PMID25406017
PMCPMC4298328
OpenAlexW2088534258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.